Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.52 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | GLA | P06280 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | CASP1 | P29466 | 2/20 | 0.38 |
| ▸ | CASP7 | P55210 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 2/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | NQO2 | P16083 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10527280 | 0.85 | MAOA (0.57) | MAOAMAOBKDM4EALDH1A1GLA | |
| SCHEMBL44256 | 0.82 | KDM4E (0.41) | MAOAMAOBKDM4EALDH1A1GLA | |
| SCHEMBL28961139 | 0.82 | MAOA (0.64) | MAOAMAOBKDM4EALDH1A1GLA | |
| SCHEMBL31413138 | 0.77 | MAOA (0.52) | MAOAMAOBKDM4EALDH1A1GLA | |
| SCHEMBL13445183 | 0.74 | KDM4E (0.56) | MAOAMAOBKDM4EALDH1A1GLA | |
| SCHEMBL10527277 | 0.73 | MAOA (0.47) | MAOAMAOBKDM4EALDH1A1GLA | |
| SCHEMBL667261 | 0.73 | MAOA (0.52) | MAOAMAOBKDM4EALDH1A1GLA | |
| SCHEMBL7552792 | 0.73 | GPR3 (0.44) | MAOAKDM4EALDH1A1GLAHPGD | |
| SCHEMBL5349939 | 0.72 | MAOA (0.61) | MAOAMAOBKDM4EALDH1A1GLA | |
| SCHEMBL7607540 | 0.70 | GPR3 (0.54) | MAOAMAOBKDM4EALDH1A1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4539816-A1 | COMPOSITIONS AND METHODS FOR AN ORAL SUPPLEMENT TO ORAL MINOXIDIL FOR THE TREATMENT OF ALOPECIA | Follea International (US) | 2025-04-23 | — | — | EP | claimed |
| WO-2025048828-A1 | COMPOSITIONS AND METHODS FOR AN ORAL SUPPLEMENT TO ORAL MINOXIDIL FOR THE TREATMENT OF ALOPECIA | FOLLEA INTERNATIONAL (US) | 2025-03-06 | — | — | WO | claimed |
| EP-3720468-B1 | TISSUE REPAIR | UNIV SUSSEX (GB) | 2024-10-30 | — | — | EP | claimed |
| US-11596668-B2 | Tissue repair | THE UNIVERSITY OF SUSSEX (GB) | 2023-03-07 | — | — | US | claimed |
| US-20210162008-A1 | TISSUE REPAIR | THE UNIVERSITY OF SUSSEX (GB) | 2021-06-03 | — | — | US | claimed |
| EP-3720468-A1 | TISSUE REPAIR | The University of Sussex (GB) | 2020-10-14 | — | — | EP | claimed |
| WO-2019110999-A1 | TISSUE REPAIR | THE UNIVERSITY OF SUSSEX (GB) | 2019-06-13 | — | — | WO | claimed |
| US-20160206579-A1 | TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2016-07-21 | — | — | US | claimed |
| US-20120027723-A1 | TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2012-02-02 | — | — | US | claimed |
| EP-2393490-A1 | TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION | INSERM - Institut National de la Santé et de la Recherche Médicale (FR) | 2011-12-14 | — | — | EP | claimed |
| CN-102274347-A | Anticancer composition and application thereof | — | 2011-12-14 | — | — | CN | claimed |
| WO-2011113904-A1 | MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2011-09-22 | — | — | WO | claimed |
| WO-2010089355-A1 | TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2010-08-12 | — | — | WO | claimed |
| WO-2010018418-A1 | FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS THERAPEUTIC AGENT PROVIDING HIGHLY BIOAVAILABLE SILICON | NOVATECH D.O.O. (HR) | 2010-02-18 | — | — | WO | claimed |
| US-4485091-A | HYDROGEN PEROXIDE, OIL IN WATER EMULSION | QUINODERM LIMITED (GB) | 1984-11-27 | — | — | US | claimed |
| EP-4539816-A1 | COMPOSITIONS AND METHODS FOR AN ORAL SUPPLEMENT TO ORAL MINOXIDIL FOR THE TREATMENT OF ALOPECIA | Follea International (US) | 2025-04-23 | — | — | EP | disclosed |
| WO-2025048828-A1 | COMPOSITIONS AND METHODS FOR AN ORAL SUPPLEMENT TO ORAL MINOXIDIL FOR THE TREATMENT OF ALOPECIA | FOLLEA INTERNATIONAL (US) | 2025-03-06 | — | — | WO | disclosed |
| US-4485091-A | HYDROGEN PEROXIDE, OIL IN WATER EMULSION | QUINODERM LIMITED (GB) | 1984-11-27 | — | — | US | disclosed |
| US-4035506-A | Fluorocarbon dermal protective compositions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1977-07-12 | — | — | US | disclosed |
| US-4017615-A | ESPECIALLY USEFUL FOR ANTIINFLAMMATORY TOPICAL CORTICOIDS | SYNTEX CORPORATION (PM) | 1977-04-12 | — | — | US | disclosed |